Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage IIIc Melanoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT01940809
What this trial is testing

Ipilimumab With or Without Dabrafenib, Trametinib, and/or Nivolumab in Treating Patients With Melanoma That Is Metastatic or Cannot Be Removed by Surgery

Who this might be right for
BRAF V600E Mutation PresentBRAF V600K Mutation PresentMetastatic Melanoma+5 more
National Cancer Institute (NCI) 15
Testing effectiveness (Phase 2)Study completedNCT01961115
What this trial is testing

Epacadostat and Vaccine Therapy in Treating Patients With Stage III-IV Melanoma

Who this might be right for
Mucosal MelanomaRecurrent MelanomaRecurrent Uveal Melanoma+8 more
Fred Hutchinson Cancer Center 11
Not applicableEnded earlyNCT02336763
What this trial is testing

Radiation Therapy in Preventing Liver Metastases in Patients With Uveal Melanoma Who HaveMonosomy 3 or DecisionDx Class 2 Disease and Are More Likely to Develop Liver Metastases

Who this might be right for
Iris MelanomaMedium/Large Size Posterior Uveal MelanomaStage IIA Uveal Melanoma+4 more
Jonsson Comprehensive Cancer Center 2
Testing effectiveness (Phase 2)Looking for participantsNCT01638676
What this trial is testing

A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients

Who this might be right for
Melanoma
University of Louisville 55
Large-scale testing (Phase 3)Study completedNCT01368276
What this trial is testing

An Extended Use Study of Safety and Efficacy of Talimogene Laherparepvec in Melanoma

Who this might be right for
Melanoma
BioVex Limited 31
Testing effectiveness (Phase 2)UnknownNCT04200040
What this trial is testing

A Clinical Study to Evaluate the Safety and Efficacy of OrienX010 in Unresectable Malignant Melanoma Patients

Who this might be right for
Melanoma (Skin)
OrienGene Biotechnology Ltd. 165
Early research (Phase 1)Active Not RecruitingNCT01955460
What this trial is testing

Genetically Modified T-Cells Followed by Aldesleukin in Treating Patients With Stage III-IV Melanoma

Who this might be right for
Metastatic MelanomaStage III Cutaneous Melanoma AJCC v7Stage IIIA Cutaneous Melanoma AJCC v7+3 more
M.D. Anderson Cancer Center 34
Testing effectiveness (Phase 2)UnknownNCT00925314
What this trial is testing

Transgenic Lymphocyte Immunization (TLI) Against Telomerase in Subjects With Stage III Melanoma

Who this might be right for
Stage IIIB Skin MelanomaStage IIIC Skin Melanoma
Cosmo Bioscience 20
Early research (Phase 1)Study completedNCT01066390
What this trial is testing

A Study on the Safety and Immunogenicity of Combined Intradermal and Intravenous Administration of an Autologous mRNA Electroporated Dendritic Cell Vaccine in Patients With Previously Treated Unresectable Stage III or IV Melanoma

Who this might be right for
Melanoma
Bart Neyns 18
Not applicableWithdrawnNCT02507076
What this trial is testing

Isolated Limb Perfusion With Melphalan in Treating Patients With Stage IIIB-IV Melanoma or Sarcoma

Who this might be right for
Basal Cell Carcinoma of the SkinEccrine Carcinoma of the SkinRecurrent Adult Soft Tissue Sarcoma+8 more
Albert Einstein College of Medicine
Testing effectiveness (Phase 2)Ended earlyNCT04902040
What this trial is testing

Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies

Who this might be right for
Advanced Bladder CarcinomaAdvanced Lung Non-Small Cell CarcinomaAdvanced Malignant Solid Neoplasm+32 more
M.D. Anderson Cancer Center 19
Early research (Phase 1)Study completedNCT03021460
What this trial is testing

Pembrolizumab and Ibrutinib in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery

Who this might be right for
Metastatic MelanomaStage III Cutaneous Melanoma AJCC v7Stage IIIA Cutaneous Melanoma AJCC v7+4 more
Mayo Clinic 20
Testing effectiveness (Phase 2)Study completedNCT02094391
What this trial is testing

Trial of Ipilimumab After Isolated Limb Perfusion, in Patients With Metastases Melanoma

Who this might be right for
In-transit Metastases Melanoma Stage IIIB and IIIC
Gustave Roussy, Cancer Campus, Grand Paris 4
Testing effectiveness (Phase 2)Study completedNCT02500576
What this trial is testing

Pembrolizumab, Standard Chemotherapy, Tumor Infiltrating Lymphocytes, and High- or Low-Dose Aldesleukin in Treating Patients With Metastatic Melanoma

Who this might be right for
Metastatic MelanomaStage IIIB Cutaneous Melanoma AJCC v7Stage IIIC Cutaneous Melanoma AJCC v7+1 more
M.D. Anderson Cancer Center 18
Testing effectiveness (Phase 2)Active Not RecruitingNCT04940299
What this trial is testing

Tocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial Carcinoma

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Locally Advanced Bladder Carcinoma+39 more
M.D. Anderson Cancer Center 35
Not applicableNo Longer AvailableNCT02416232
What this trial is testing

Access Study of Trametinib for Subjects With Advanced Unresectable (Stage IIIc) or Distant Metastatic (Stage IV) BRAF V600E/K Mutation Positive Cutaneous Melanoma

Who this might be right for
Melanoma
GlaxoSmithKline
Large-scale testing (Phase 3)Study completedNCT00019682
What this trial is testing

Aldesleukin With or Without Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Melanoma

Who this might be right for
Recurrent MelanomaStage IIIA Skin MelanomaStage IIIB Skin Melanoma+2 more
National Cancer Institute (NCI) 185
Early research (Phase 1)UnknownNCT06556004
What this trial is testing

Phase 1 Study Using TRIMELVax for Stage IIIC / IV Melanoma Patients

Who this might be right for
Melanoma Stage IIIcMelanoma Stage IV
University of Chile 20
Testing effectiveness (Phase 2)Study completedNCT01258855
What this trial is testing

Aldesleukin With or Without Ziv-Aflibercept in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery

Who this might be right for
Metastatic MelanomaRecurrent MelanomaStage III Cutaneous Melanoma AJCC v7+4 more
National Cancer Institute (NCI) 84
Testing effectiveness (Phase 2)Study completedNCT00470470
What this trial is testing

Imatinib Mesylate in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery

Who this might be right for
Acral Lentiginous Malignant MelanomaRecurrent MelanomaStage IIIA Melanoma+3 more
National Cancer Institute (NCI) 30
Next Page